nalysis of emergent bivalent antibody binding identifies the molecular reach as a critical determinant of SARS-CoV-2 neutralisation potency
Huhn A., Nissley DA., Wilson D., Kutuzov M., Donat R., Tan TK., Zhang Y., Barton M., Liu C., Dejnirattisai W., Supasa P., Mongkolsapaya J., Townsend A., James W., Screaton G., van der Merwe PA., Deane C., Isaacson S., Dushek O.